Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of XELOX and Toripalimab in the Neoadjuvant Treatment of Stage II/III Gastric or GE Junction Adenocarcinoma

NCT04119622 is registered in ClinicalTrials.gov with Aiping Zhou as lead sponsor.

NCT NCT04119622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of XELOX and Toripalimab in the Neoadjuvant Treatment of Stage II/III Gastric or GE Junction Adenocarcinoma
Lead sponsor
Aiping Zhou
Phase
Phase 2
Overall status
Unknown status
Start date
October 8, 2019
Completion date
October 31, 2024
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer stage ii, gastric cancer stage iii